Stay updated on Pembrolizumab + Nab-Paclitaxel in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab + Nab-Paclitaxel in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab + Nab-Paclitaxel in NSCLC Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 to the page footer. Removed the government funding lapse notice about site operating status.
    Difference
    0.5%
    Check dated 2026-02-11T09:26:29.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Notice: A site-wide funding notice banner was added with a new revision tag (v3.4.1). The related topics 'Lung cancer' and 'MedlinePlus Genetics' were removed.
    Difference
    0.6%
    Check dated 2026-02-04T05:50:19.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    UI and metadata updates were made: a glossary display option and new related topics (Lung cancer, MedlinePlus Genetics) were added. The revision indicator was updated to v3.4.0 with related QC metadata changes.
    Difference
    0.4%
    Check dated 2026-01-28T03:48:39.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The page removed the topic tags 'Lung cancer' and the related topic 'MedlinePlus Genetics', reducing navigational context without altering the study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-21T02:18:08.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    Revision updated to v3.3.4; the previous v3.3.3 entry was removed.
    Difference
    0.1%
    Check dated 2026-01-14T01:42:50.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    Added Lung cancer tag and related topics, including a link to MedlinePlus Genetics. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-12-30T16:31:54.000Z thumbnail image

Stay in the know with updates to Pembrolizumab + Nab-Paclitaxel in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Nab-Paclitaxel in NSCLC Clinical Trial page.